Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ:CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that Chief Executive Officer Myron Holubiak will deliver a virtual presentation at the Life Sciences Investor Forum on Thursday, June 25, 2020 at 11:00 AM ET.
Event: Life Sciences Investor Forum
Presentation Date: Thursday, June 25, 2020
Presentation Time: 11:00 AM ET
Mr. Myron Holubiak will present an update on the Company, including its Phase 3 pivotal trial with Mino-Lok® that is currently more than half enrolled and its option to license a novel stem cell therapy for acute respiratory distress syndrome (ARDS) in COVID-19 patients. This presentation will be a live, interactive online event where investors can ask the Company questions in real-time. An archived webcast will also be made available after the event.
While attendance at this virtual event is free, it is recommended that investors pre-register at www.lifesciencesinvestorforum.com.